KRAS and non-small cell lung carcinoma: This review summarizes recent advances aimed at enhancing intracranial tumor control and overall survival in patients with NSCLC brain metastases through the use of next-generation KRAS<sup>G12C</sup> inhibitors and multimodal therapies.